Robert Wessman became the Executive Chairman of Alvogen in July 2009 and is now both the Chairman & CEO of the group.

Kevin Bain is Chief Financial Officer for Alvogen. With more than 25 years of financial, operations and general management experience

Doug Drysdale is the Chief Executive Officer of Alvogen America. Recognized in 2011 as an Emerging Pharma Leader by Pharmaceutical Executive magazine

Svafa Gronfeldt is the Chief Organizational Development Officer of Alvogen. She is responsible for the structure, strategy and human resources needed for a fast growing organization.

With more than 19 years experience in the generic pharmaceutical industry, a proven track record of building strong cohesive teams and consistently demonstrating the ability to support sustainable business growth, Chris is responsible for the Global Supply Chain of Alvogen.

Laurentiu Scheusan is the EVP of Sales in Central and Eastern Europe. He joined the Company in January 2010, after three and a half years with the generic pharmaceuticals company Actavis Group.

Georg Ingram began his career in 1994 at Biochemie GmbH in Austria – later Sandoz GmbH – in marketing. From 1997 to 2003, he served as Head of Global Business Development.

Peter Keil is the EVP of Sales in Asia Pacific and leads the commercial activities for all countries in the region (excl. China).

is Alvogen's Vice President Global Quality Affairs. His main role is to oversee and manage Alvogen's compliance with respect to regulatory requirements for manufacturing and other disciplines that are governed by Good Compliance Practices (GxP).